SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social activity and trading volume as investors discuss its technical strengths, including post-quantum security and real-world asset (RWA) potential. The community is actively debating the impact of recent leadership changes and the broader market's anticipation of upcoming regulatory clarity.

Maul Coin

Maul Coin is generating buzz as an early-stage community-driven project, with supporters actively rallying to increase its holder count and social media presence in hopes of driving a significant market cap expansion. The community is focused on organic growth and transparency, eagerly awaiting official charting status while coordinating promotional efforts across various platforms to maintain momentum.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is trending as investors debate its long-term potential following a steep post-launch decline, with the community split between those accumulating at current price levels and others concerned about future token dilution. Supporters are actively discussing the project's high staking rewards and parallel processing technology as indicators of future value, while critics highlight low network activity and a challenging broader crypto market environment.

GraniteShares ETF Trust - GraniteShares 2x Long COIN Daily ETF

GraniteShares 2x Long COIN Daily ETF

CONL is trending as the community closely monitors the upcoming Senate Banking Committee markup of the CLARITY Act, viewing potential regulatory progress as a major catalyst for Coinbase and the broader crypto sector. Investors are also actively debating its long-term viability, with many using the stock's recent volatility to accumulate positions in anticipation of a potential rebound linked to Coinbase's earnings and Bitcoin's price trajectory.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating community buzz due to its ultra-low circulating supply and small market cap, which investors believe make it primed for significant price volatility and potential gains. Discussions are heavily focused on the hope for a resurgence in the NFT market, new exchange listings, and the token's historical ability to move rapidly with even minor increases in trading volume.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is trending as the community closely monitors the outcome of the high-profile court battle involving Craig Wright, while simultaneously celebrating technical milestones like the Teranode testnet's ability to process over a million transactions per second. Investors are actively debating the token's long-term utility as the original Bitcoin protocol versus its significant regulatory hurdles and recent legal rulings, with many HODLers pointing to its scalability and low-cost microtransactions as catalysts for a potential rebound.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

The Zebec Network (ZBCN) community is actively debating the project's long-term utility versus its recent price performance, with many holders focusing on institutional partnerships and the potential for a breakout following the conclusion of token unlocks. While skeptics highlight the high circulating supply and recent downward trends, advocates remain bullish on the network's integration into payroll systems and anticipated announcements at industry events.

The ArcBlock project was created to create the first Blockchain ecosystem in the world. Develop and develop decentralized applications (DApp) according to objectives. ArcBlock, one of the ICO projects emerging in early 2018. Just launched on 3/1/2018, ArcBlock has quickly attracted the attention of technology as well as investors. ArcBlock brings great technological advancements that will open the third generation of blockchain applications.  Arcblock work by bridging the gap between different blockchains and their respective ecosystems has not been easy. There are some solutions which attempt to solve this problem, but it is evident there is plenty of room for competition in this regard. Building an open chain access layer capable of spanning multiple new and existing blockchains is a very interesting business model.  Building a new ecosystem meant to connect various chains will not be easy. As of right now, the team has completed its token sale, and the first public release candidate for the Open Chain Access Protocol will be released in Q3. Early 2019 will herald the introduction of more technical features and an Ethereum Blocklet prototype.

ArcBlock (ABT) is seeing heightened market activity and increased trading volume as community members speculate on potential AI integration and exchange listings, sparking both bullish price targets and skepticism regarding the project's utility. Conversations are dominated by long-term holders debating the legitimacy of recent partnership announcements and the token's ability to sustain upward momentum amid ongoing volatility.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is currently experiencing significant market attention, driven by institutional accumulation and investor anticipation regarding pivotal Phase 3 trial data for Duravyu. The community is actively debating the company's competitive positioning, specifically evaluating its Duravyu candidate against rival TKI treatments in the wet AMD and DME markets, while monitoring ongoing legal developments and management's strategic communication.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Structure Therapeutics ($GPCR) is trending sharply following positive Phase 2b clinical data for its oral GLP-1 drug, aleniglipron, which showed weight loss results that have fueled intense speculation regarding the company as a prime M&A target. Investors are actively debating the drug's efficacy and tolerability profile compared to competitors like Viking Therapeutics ($VKTX), with the community closely analyzing management's communication style and potential buyout interest from big pharma.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Search

Altaf